The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease

COVID-19 Clinical Trial

Official title:

The Effect of Patient's Perceptions for COVID-19 on the Inflammatory Bowel Disease-related Healthcare Utilization in the Hyperepidemic Area

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04387279
• Other study ID #: 2020-04-070
• Status: Recruiting
• Start date: April 24, 2020
• Est. completion date: March 30, 2021

Study information

• Verified date: May 2020
• Source: Keimyung University Dongsan Medical Center
• Contact: Yoojin Lee, M.D.
• Phone: 82-53-258-7739
• Email: doctorlyj[@]naver.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The rapid spread of COVID-19 is expected to have a significant impact on medicine as well as all sectors worldwide. In particular, inflammatory bowel disease (IBD) is a chronic immune disease in which remission and activation are repeated and must be treated consistently throughout life. In addition, patients with IBD may be vulnerable to various infectious diseases due to the immuno-compromised state due to the use of immuno-suppressants or biological agents. During a pandemic, patients with IBD may postpone hospital visits due to concerns about infection with COVID-19, and if they cannot continue drug treatment, there is a concern about the flare up IBD disease activity. Therefore, in this study, we would like to investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital ultilization.

Description:

Background: In the epidemic area of COVID-19, emergency treatment of chronic diseases other than COVID-19 can be limited. Therefore, it is important to reduce the risk of exposure to COVID-19 in patients with chronic immune diseases such as IBD, but it is most important to manage well so that the underlying diseases are not exacerbated at times when emergency medical treatment may be difficult. However, there is a lack of evidence on the management policy of chronic immune diseases in the current epidemic, and only expert opinions are being presented.

Aim: To investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital utilization.

Material and method: This study is a multicenter, prospective, cross-sectional survey which will be consulted in Keimyung University Dongsan Medical Center and Yeungnam University Hospital. Patients with IBD aged above 18 will enrolled and surveyed about their perception about COVID-19 and status of hospital utilization during pandemic period. Patients' demographics and disease-related variables will be evaluated to identify clinical significances.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 800
• Est. completion date: March 30, 2021
• Est. primary completion date: March 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with inflammatory growth disease, those who agreed to participate in this study

Exclusion Criteria:

• Those who are unable to understand or answer the questionnaire

• Those who declined to participate in this study

Related Conditions & MeSH terms

• COVID-19
• Facilities and Services Utilization
• Inflammatory Bowel Diseases
• Perception, Self

Intervention

Other:
• Interview
Surveys on medical use patterns and patient's perceptions about COVID-19

Locations

Country	Name	City	State
Korea, Republic of	KeimyungUniversity	Daegu	Jung-gu

Sponsors (2)

Lead Sponsor	Collaborator
Keimyung University Dongsan Medical Center	Yeungnam University College of Medicine

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient's perception of COVID-19 and medical use patterns	Correlation between patient's perception of COVID-19 and medical use patterns during the pandemic period	1day
Secondary	Exacerbation of symptoms	Exacerbation of symptoms in patients with IBD during the pandemic period	1day